Searched for
INDUSTRIAL BIOTECH SEGMENT
Samsung minority union challenges bonus deal in courtA labour union representing several thousand Samsung Electronics employees asked a court on Tuesday to nullify a bonus agreement between th...
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Tata Chemicals CEO R Mukundan takes over as CII president for 2026-27R Mukundan, CEO of Tata Chemicals, has assumed the presidency of the Confederation of Indian Industry (CII) for 2026-27, succeeding Rajiv M...
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
US stock market today: why Dow Jones crashing big while S&P 500 and Nasdaq are rising? Dow down by 200 points as oil surge, Fed jitters, and Big Tech earnings split market directionUS stock market today: Why Dow Jones Industrial Average falls while S&P 500 and Nasdaq Composite hold steady? US stock market today shows a...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Inside China’s ‘Magic’ factories: The tech playbook India can’t ignoreChina's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...
BIRAC fuels innovation with Rs 4,200 crore funding across 15 lakh startups and entrepreneursIndia's Biotechnology Industry Research Assistance Council, BIRAC, marked its 14th Foundation Day. It has significantly boosted India's bio...
Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
India targets $300 billion worth bioeconomy by 2030Bioeconomy is the production, utilization, and conservation of biological resources, including related knowledge, science, technology, and ...
Karnataka will tap PLI to build its bio-pharma & medical devices sector, says Ashwath NarayanKarnataka's bio-economy, currently valued at $ 24.4 billion contributing 33% of the national share, is on course to achieve $ 50 billion by...
- Indian Biotech industry growing at 15% annually, abundant job opportunities
'Many pharmaceutical companies have established R&D centers in India and are considering tapping India’s talent', says Lawrence Ganti.
- Indian Biotech Industry's five year growth at 19%: E&Y
The biotechnology industry in India has been growing at a CAGR of 19% rate over the last 5 yrs, says a report by the global audit & advisor...
- Indian biotech industry at critical juncture, global biotech stabilizes: Report
Indian biotech industry at critical junction, while global biotech industry showed a 2nd straight yr of increasingly stable financial perfo...
- India's biotech sector to grow 20% in foreseeable future
Mazumdar-Shaw said the size of the country's biotech sector had reached USD 3.5 billion in 2010 and is poised for robust growth in all segm...
- Indian biotech sector rebounds on global recovery
India's biotech industry bounced to high growth in fiscal 2009-10 to post revenues of $4 billion, a whopping 52 per cent over the previous ...
- Pharmaceutical firm to invest USD 300 mn in Malaysia
Malladi Drugs and Pharmaceutical Ltd will invest up to USD 300 million over the next three to five years to set up its global "one-stop sho...
- Indian biotechnology sector to touch $ 5 bn by 2010: Report
Indian biotechnology sector is expected to become a five bn-dollar (around Rs 23,400 crore) industry by 2010, says a report.